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In recent years, the function of retinoic acid (RA) in limb development has been debated. In this
issue of Cell Reports, Cunningham et al. show that RA antagonizes fibroblast growth factors for
limb initiation, but not for limb patterning.The development of the limb has long
served as amodel for exploring themech-
anisms of pattern formation from nascent
organ primordia into a mature structure
with stereotypical morphology. Retinoic
acid (RA) has pleiotropic effects when
exogenously applied to developing em-
bryos. But what roles does endogenous
RA have in limb development? In this
issue of Cell Reports, Cunningham et al.
(2013) use powerful mouse genetic ap-
proaches to reveal antagonism between
RA and fibroblast growth factors (FGFs)
in limb development. Their findings lead
to two surprising conclusions that contra-
dict current models.
The first conclusion concerns proximal-
distal (PD) limb patterning. In all animals
with four limbs, the most proximal part
(upper arm or leg) contains one long
bone, and the central part contains two
long bones. The most distal part (hand
and foot) contains bones of various
numbers and lengths, depending on the
species. The limb skeleton is constructed
from limb bud mesenchyme, which is
derived from lateral plate mesoderm
(LPM), and the skeletal pattern is consid-
ered to be a patterning output.
Models for PD patterning have been
examined for 40 years (Summerbell
et al., 1973; Zeller et al., 2009). On the ba-
sis of embryological andmolecular data, a
‘‘two-signal model,’’ in which opposing
diffusible signals from the distal and
proximal domains pattern limb mesen-
chymal cells along the PD axis, is
currently accepted (Tabin and Wolpert,
2007). In this model, FGFs (FGF4, FGF8,
FGF9, and FGF17) emanating from the
specialized ectoderm along the distaledge of the limb bud serve as cell-survival
factors and specify the distal domain
(Mariani et al., 2008). RA is thought to
specify proximal cell fate (Cooper et al.,
2011; Rosello´-Dı´ez et al., 2011). In a
simplified view, antagonism between
these signals patterns the limb along the
PD axis.
Although the function of ectoderm-
derived FGFs has been widely accepted
on the basis of mouse genetics and chick
manipulation experiments, the function
of RA is debated (Zhao et al., 2009).
In relation to limb development, RA is
produced in the trunk and is thought to
diffuse into the proximal part of the limb
bud. To investigate roles of RA during
limb development, Cunningham et al.
(2013) used two mouse mutants to abro-
gate RA production. Raldh2/ embryos
die before the onset of limb outgrowth,
but Rdh10 mutants, which harbor a point
mutation that results in undetectable
levels of RA production, survive until
E10.5–E14.5. Rdh10 mutants show small
forelimb buds and normal hindlimb buds,
allowing for the analysis of RA require-
ment in limb patterning (Rdh10 and
Raldh2 catalyze sequential reactions in
RA synthesis) (see Duester, 2008).
Specification of proximal fate was
evaluated by the expression of Meis1
and Meis2. In Raldh2/ embryos and
Rdh10 mutants, Meis1 and Meis2 are
expressed in the LPM before limb
outgrowth and in the proximal domain of
the limb bud, respectively, suggesting
that RA is not required to specify
the proximal domain. Furthermore, the
authors demonstrated that RA response
element (RARE)-LacZ, a widely-used RACell Reports 3, May 30, 2013 ª2013 The Authoreporter transgene, is sensitive enough
to detect RA at levels below physiological
concentrations in embryonic tissues. The
lack of detectable RARE-LacZ signals in
Rdh10 mutants and Raldh2/ embryos
indicates that RA production in these
mutants is indeed significantly impaired.
These results illustrate a significant
discrepancy in the two-signal model.
A possible explanation for the discrep-
ancy involves the way RA function was
originally examined. In previous chick
experiments, RA and RA antagonists
were administered at high concentrations
(mM to mM), which could cause terato-
genic effects of RA and/or off-target
effects of antagonists. Thus, a genetic
approach in combination with monitoring
RA signaling offers a compelling interpre-
tation. A criticism is that undetectable
RA levels may be exerting undetected
effects. Targeted Rdh10 knockout em-
bryos showed more severe defects in
comparison to Rdh10 point mutants
used in the study. This suggests that
undetectable levels of RA rescued sur-
vival of Rdh10mutants. Additionally, local
RA concentrations and responses to
RA at single-cell resolution in developing
limbs are still unknown. Nonetheless, the
data collectively show that RA is unlikely
to regulate proximal gene expression in
limb buds.
The second unexpected result involves
the role of FGF8 in limb bud initiation.
Fgf8 is expressed in the cardiac meso-
derm, and trunk tissue is an active RA
signaling domain; thus, an intersection
of RA and FGF close to the heart is
created. In Rdh10 point mutant and
Raldh2/ embryos, the cardiac Fgf8rs 1337Open access under CC BY-NC-ND license.
domain is expanded into the forelimb
field, indicating that RA and FGF8 antago-
nize one another. Analyses by Cunning-
ham et al. (2013) indicate that the
expanded FGF8 negatively impacted
forelimb progenitors. This interpretation
was supported by a loss of Tbx5-express-
ing forelimb progenitors in embryos
cultured with FGF8, whereas cardiac
Tbx5 was not affected. An additional
genetic rescue experiment was also per-
formed with zebrafish neckless mutants,
which possess mutations in the raldh2
gene and do not develop the pectoral fin
(equivalent to the forelimb). Transgenic
inhibition of FGF signaling in neckless
mutants resulted in pectoral fin develop-
ment. Collectively, these results indicate
that RA antagonism restricts cardiac
FGF8, whose expansion in RA-deficient
embryos causes a loss of forelimb pro-
genitors. In other words, RA does not
directly induce limb initiation but, rather,
prevents cardiac FGF8 from blocking the
process.
This conclusion was surprising, given
that a number of chick manipulation ex-
periments have shown that the applica-
tion of FGF8-soaked beads to trunk tissue
induced ectopic limb formation. So, do
FGFs promote or inhibit limb bud initia-1338 Cell Reports 3, May 30, 2013 ª2013 Thtion? There is no Fgf gene whose loss, at
least individually, causes failure to initiate
limb bud outgrowth. For instance,
Fgf10/ embryos lack the limb but
initiate limb outgrowth (Sekine et al.,
1999). If ectopic cardiac FGF8 represses
limb initiation, but FGF8 beads do the
opposite, then the timing of gene manipu-
lation may explain the discrepancy. It is
known that chick LPM is responsive to
exogenously applied FGFs for a brief
period, during which FGFs can stimulate
ectopic outgrowth. Prior to this window,
FGFs may have different effects. A simple
test to resolve the discrepancy would
be to apply FGF8 beads to the limb-bud-
forming region of chick embryos at earlier
stages.
The paper by Cunningham et al. (2013)
provides important insights into the
mechanisms of two aspects of vertebrate
limb development, PD patterning and
limb initiation, through the analysis of
RA-FGF antagonism. RA is dispensable
for limb PD patterning, and FGF8, which
is restricted by RA to cardiac tissue,
can repress forelimb initiation. These
conclusions may force a significant shift
in how we think about limb development.
Even so, we still lack answers to long-
standing questions about the mecha-e Authors Open access under CC BY-NC-ND license.nisms of PD patterning and initiation of
the limb. Thus, despite decades of inten-
sive study, limb researchers still have
some work to do.REFERENCES
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